Related Experiment Videos

The myelodysplastic syndromes: diagnostic criteria and laboratory evaluation

P J Ho¹, J Gibson, P Vincent

¹Haematology Department, Royal Prince Alfred Hospital, Camperdown, New South Wales.

|July 1, 1993

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR.

Leukemia·2016

Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study.

Leukemia·2016

Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade.

Leukemia·2016

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.

Leukemia·2015

Defining response to anti-VEGF therapies in neovascular AMD.

Eye (London, England)·2015

Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group.

Internal medicine journal·2015

See all related articles